BackOnyx Healthcare Overview
Onyx Healthcare Inc.

Onyx Healthcare Return on Equity

Latest ROE for Onyx Healthcare: 8.88% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

8.88%

Return on Equity

8.88%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Onyx Healthcare (6569.TWO) FAQ

The latest ROE for 6569.TWO is 8.88%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Onyx Healthcare's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, 6569.TWO currently prints 8.88% for ROE, while the sector average sits near 11.3%. That is roughly 21.3% below the sector mean. Large gaps often invite a closer look at Onyx Healthcare's growth, margins, and balance sheet.

Return on Equity shows how effectively Onyx Healthcare converts resources into returns. At 8.88%, 6569.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 6569.TWO's ROE (8.88%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.